Sustainability
of product performance, human factors, operational processes and environmental controls, and textiles should be considered within this broader context. The discussion has moved beyond whether
reusable systems can meet standards. The more relevant consideration now is how performance is assessed across the full lifecycle – and how visibility, traceability and assurance are maintained.
Human factors and practical performance Clinical decision-making is influenced not only by compliance, but also by user experience. Comfort, fit, breathability and ease of movement can all affect staff acceptance of surgical gowns, particularly during long and complex procedures. Modern reusable textiles have evolved considerably in this regard, with engineered materials designed to balance performance with breathability and wearability. Operational practicality is another important consideration. The perceived convenience of single-use systems, which are used once and disposed of with no requirement for return, can be attractive in fast-paced settings. However, it is essential to assess convenience against broader operational realities.
Single-use dependency requires
uninterrupted supply continuity, predictable stock availability, storage capacity and waste handling infrastructure, whereas reusable systems rely on effective logistics, disciplined returns and confidence in processing capability. The question here is not simply which option appears most convenient at point of use, but which model delivers the most resilient, assured and efficient system overall.
Strengthening supply resilience If the COVID-19 pandemic demonstrated anything, it was the fragility of global healthcare supply chains. Disruptions to international manufacturing, freight delays, allocation pressures and shortages of critical products exposed vulnerabilities that many healthcare organisations had not previously anticipated at scale.10
Surgical PPE and related consumables
became emblematic of these pressures, with procurement teams forced to navigate scarcity, pricing volatility and uncertain supply continuity under exceptional circumstances. The pandemic also highlighted the challenges
associated with rapidly scaling supply in response to unexpected demand. As a result, many Trusts placed greater emphasis on resilience, continuity planning and maintaining
access to critical products during periods of disruption – considerations that continue to influence procurement decisions today. While the acute phase of disruption experienced during the COVID-19 pandemic has passed, the broader lessons remain highly relevant. Healthcare systems continue to operate in an environment shaped by geopolitical instability, inflationary pressures, raw material volatility and global logistics uncertainty. Dependence on long, complex international supply chains can therefore still present significant risk. This is where the infrastructure behind surgical
textile systems becomes increasingly important. Single-use models typically rely on ongoing manufacturing output, uninterrupted freight movement, stock-holding capacity and consistent supplier performance. Reusable models supported by established domestic reprocessing infrastructure shift some elements of risk away from pure purchase dependency towards managed operational continuity. This can help mitigate allocation risk, sudden price escalation and quality variability across suppliers. For theatre teams, supply continuity is more than simply a procurement issue – it is a clinical one, with delayed procedures, emergency substitutions, stock constraints and
When you need to bring your A-Game!
The i-gel®
Plus-A is the latest device in the i-gel®
• Larger gastric channel •
Intubation ramp • Longer cuff tip
For further information, please scan the QR code or visit:
www.intersurgical.co.uk/info/igel-anaesthesia
lnteract with us
www.intersurgical.co.uk i-gel-plus-anaesthesia-Half-page-CSJ.indd 1 19/01/2026 11:15:19 July 2026 I
www.clinicalservicesjournal.com 43
Plus range, specially designed for use in the Anaesthesia setting.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
